| THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL | |
| Wei, Lai; Xu, Xiaoyuan; Zheng, Sujun; Guan, Yujuan; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng | |
| 2019 | |
| 卷号 | 70 |
| 收录类别 | SCIE |
| 会议录 | HEPATOLOGY
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0270-9139 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4262853 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Wei, Lai,Xu, Xiaoyuan,Zheng, Sujun,et al. THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论